Treatment of neuroinflammatory conditions using antibodies directed against MCAM

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9017682
APP PUB NO 20130017206A1
SERIAL NO

13617617

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods, uses, agents and compositions useful for the diagnosis, prevention and/or treatment of inflammatory conditions, such as neuroinflammatory conditions such as multiple sclerosis, and for the identification and selection of inflammatory cytokine-secreting T cell or a precursor thereof, based on the expression and/or modulation of melanoma cell adhesion molecule (MCAM) are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VAL-CHUM LIMITED PARTNERSHIP3535 QUEEN-MARY ROAD SUITE 220 MONTREAL QUEBEC H3V 1H8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arbour, Nathalie Outremont, CA 3 30
Cayrol, Romain Montreal, CA 3 30
Prat, Alexandre Outremont, CA 6 44

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 28, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00